UroGen Pharma Ltd. (URGN)
NASDAQ: URGN · Real-Time Price · USD
11.20
-0.25 (-2.18%)
At close: Mar 28, 2025, 4:00 PM
11.35
+0.15 (1.34%)
After-hours: Mar 28, 2025, 5:21 PM EDT
UroGen Pharma Market Cap
UroGen Pharma has a market cap or net worth of $516.26 million as of March 28, 2025. Its market cap has decreased by -4.26% in one year.
Market Cap
516.26M
Enterprise Value
399.47M
1-Year Change
-4.26%
Ranking
Category
Stock Price
$11.20
Market Cap Chart
Since May 4, 2017, UroGen Pharma's market cap has increased from $167.38M to $516.26M, an increase of 208.44%. That is a compound annual growth rate of 15.32%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 735.22B |
| UnitedHealth Group | 473.34B |
| Johnson & Johnson | 394.49B |
| AbbVie | 363.09B |
| Novo Nordisk | 305.46B |
| Abbott Laboratories | 228.05B |
| Merck & Co. | 226.18B |
| AstraZeneca | 225.00B |